Security key
501575104
Kymera Therapeutics, Inc. - COMMON STOCK (KYMR)
CUSIP: 501575104
Q2 2021 13F Holders as of 30 Jun 2021
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 26,479,657
- Total 13F value
- $1,284,263,574
- Share change
- +3,675,751
- SEC-reported price per share
- $48.50
- Number of holders
- 109
- Value change
- +$188,105,374
- Number of buys
- 80
- Number of sells
- 39
- Shares outstanding
- 81,496,373
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2021
Institutions
109
Top holders
10
KYMR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2021
Previous quarter: Q1 2021
Kymera Therapeutics, Inc. SEC filings
Kymera Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 501575104
Recent filing periods:
Ownership snapshot
Top reported holders of KYMR - Kymera Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
15/15
Latest evidence
31 Mar 2021
13F
Lead comparable stake: 3.2%
Showing 1-6 of 15 holder rows.
Quick read
BVF INC/IL leads the comparable SEC ownership view at 3.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BVF INC/IL's linked filing trail.
Comparable ownership
Top 5
BVF INC/IL
3.2%
Redmile Group, LLC
3.2%
FMR LLC
2.9%
BAKER BROS. ADVISORS LP
2.4%
VANGUARD GROUP INC
2.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BVF INC/IL |
13F
Company
|
3.2%
|
$102,227,000
2,630,658 shares
|
— | 31 Mar 2021 |
| Redmile Group, LLC |
13F
Company
|
3.2%
|
$101,158,000
2,603,139 shares
|
— | 31 Mar 2021 |
| FMR LLC |
13F
Company
|
2.9%
|
$91,411,000
2,352,338 shares
|
— | 31 Mar 2021 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
2.4%
|
$76,135,000
1,959,211 shares
|
— | 31 Mar 2021 |
| VANGUARD GROUP INC |
13F
Company
|
2.1%
|
$67,318,000
1,732,345 shares
|
— | 31 Mar 2021 |
| Deer IX & Co. Ltd. |
13F
Company
|
2%
|
$64,526,000
1,660,471 shares
|
— | 31 Mar 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
109
Shares
26,479,657
Rows available
109
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
94
Q2 2021 holders
109
Holder diff
15
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q2 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend